WHO Introduces Groundbreaking list of new medicines to Combat Multiple Infectious Diseases

▴ new medicine list
In a significant development, the World Health Organization (WHO) has recently released the 23rd edition of the Model Lists of Essential Medicines (EML) and the 9th edition of the Essential Medicines for Children (EMLc). These updated lists, published in July 2023, include notable additions of new medicines aimed at treating various health conditions, including multiple sclerosis, cancer, infectious diseases, and cardiovascular conditions.

The EML and EMLc serve as internationally recognized guides to assist countries' healthcare systems in prioritizing effective and affordable medications. Updated every two years, the WHO's new editions have expanded the total number of medications listed on the EML and EMLc to 502 and 361, respectively

Among the noteworthy additions to the 2023 list are three medications specifically designed to slow down the progression of multiple sclerosis (MS), a chronic nervous system disease that affects 2.8 million people worldwide One of these drugs, rituximab, which is typically used to treat certain cancers and autoimmune diseases, has been recommended for off-label use in treating MS due to its proven efficacy and safety

However, it is worth noting that despite requests from researchers in the world, obesity medications were not included in the list, the WHO committee rejected the application, citing the "uncertain long-term clinical benefit and safety in this patient population"

In an important milestone, the guidelines also recommend the use of "polypills" for the first time in the treatment of heart disease and other cardiovascular issues Polypills are combinations of medications that help lower blood pressure, reduce cholesterol, regulate heartbeat, and may even include aspirin. Research has shown that these polypills can reduce the risk of cardiovascular problems by nearly 40%

Similarly, risdiplam for treating spinal muscular atrophy, donepezil for the treatment of dementia due to Alzheimer's disease, CAR-T cell therapy for lymphoma, and fast-acting oral transmucosal fentanyl for breakthrough cancer pain were not included in the updated lists

The WHO's release of the new EML and EMLc editions is a significant step forward in improving healthcare access and addressing a range of health conditions worldwide. By including effective and affordable medications for multiple sclerosis, cancer, infectious diseases, and cardiovascular issues, the WHO aims to provide countries with crucial guidance for their healthcare systems.

This update underscores the importance of research and innovation in the field of medicine, as new treatments continue to emerge that can positively impact the lives of millions globally. With the introduction of these new medicines, healthcare providers and policymakers will have access to updated information to help them make informed decisions in selecting appropriate treatments for their patients.

Tags : #who #medicines #cancermedicines #2023list #2023medicines #whoupdates #hospitalupdates #healthnews #medicineupdates #worldhealthorganisation #doctorsupdates #pills #updates

About the Author

Harsh Rathod

Dont judge a book by its cover- that was just my favourite line . When i am not here, I make music, write poems and learning about the healthcare sector has always been on my mind. So here I am exploring and creating content for you all to read:)

View Profile

Related Stories

Loading Please wait...


Trending Now

Seminar on RERA: Concerns in Real Estate heldDecember 09, 2023
Commonwealth youth leaders want action, not just rhetoric at COP28December 09, 2023
South India’s biggest Gaushala, Satyam Shivam Sundaram Gau Nivas to conduct Annakut Celebrations on Sunday on the eve of its 23rd AnniversaryDecember 08, 2023
Center for Diagnostics and Telemedicine Introduces Groundbreaking Service – Preliminary Clinical and Technical Testing for Medical SoftwareDecember 08, 2023
FTCCI to hold a Seminar on RERA: Concerns in Real EstateDecember 08, 2023
Adoption of Public Health Strategies and Early Detection Key for Cancer Mitigation: ExpertsDecember 08, 2023
Are online spaces safe for women?December 08, 2023
Prescribing Equality: Tackling Gender Disparities in India's Healthcare LeadershipDecember 07, 2023
Digitalizing Health: Generative AI's Impact Amplified by AWS Cloud in IndiaDecember 07, 2023
Eyes on the Future: Dr. Agarwal's Group Channels Rs 100 Crore for Cutting-edge Eye Hospitals Across KeralaDecember 06, 2023
Organ Transplant Scandal: Apollo Hospital Faces Government InquiryDecember 06, 2023
Breaking Barriers in Cancer Treatment: Max Healthcare's CAR-T Therapy PartnershipDecember 06, 2023
Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR StudyNovember 22, 2023
Powering the Future: China's Biodegradable Wireless System for Bioelectronic InnovationNovember 22, 2023
IMS BHU Pioneers Advanced Cardiac Care: Unveiling Cutting-Edge Technologies for Precise DiagnosisNovember 18, 2023
Inito's $6 Million Boost: Transforming Women's Health with AI-Backed Fertility MonitoringNovember 18, 2023
Madras High Court Advocates for Equality: PG Medical Students to Receive Incentive Marks for COVID-19 DutyNovember 18, 2023
Next-Gen Healthcare: CarePods and AI Redefine the Patient ExperienceNovember 17, 2023
Air Quality Crisis: Alarming Rise in Premature Births Linked to Air Quality in Begusarai, BiharNovember 17, 2023
Limerick Contest-2023: A Celebration of Wit and PoetryNovember 17, 2023